Richard Williams

Richard Williams

Chief Tech/Sci/R&D Officer at KINNATE BIOPHARMA INC.

Net worth: 138 222 $ as of 30/03/2024

55 year
Health Technology
Consumer Services
Electronic Technology

Profile

Richard Williams is currently the Chief Medical Officer at Kinnate Biopharma, Inc. He previously worked as a Clinical Research Medical Director at Amgen, Inc. from 2010 to 2012, as a Senior Medical Director at Puma Biotechnology, Inc. from 2012 to 2015, as the Head-Early Development Oncology Group at Amgen, Inc. from 2016 to 2017, as the Group Director-Medical at GRAIL LLC in 2017, and as the Chief Medical Officer & Head-Oncology Programs at Wuxi NextCode Genomics USA, Inc. from 2018 to 2020.
Dr. Williams holds a doctorate degree from The University of Queensland.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
12/03/2024 51,963 ( 0.11% ) 138 222 $ 30/03/2024

Richard Williams active positions

CompaniesPositionStart
KINNATE BIOPHARMA INC. Chief Tech/Sci/R&D Officer 31/05/2020
All active positions of Richard Williams

Former positions of Richard Williams

CompaniesPositionEnd
Chief Tech/Sci/R&D Officer 31/05/2020
Chief Tech/Sci/R&D Officer 31/01/2018
AMGEN INC. Corporate Officer/Principal 31/12/2016
PUMA BIOTECHNOLOGY, INC. Chief Tech/Sci/R&D Officer 31/08/2015
AMGEN INC. Corporate Officer/Principal 31/10/2012
See the detail of Richard Williams's experience

Training of Richard Williams

The University of Queensland Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Richard Williams's experience

Connections

100 +

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
AMGEN INC.

Health Technology

PUMA BIOTECHNOLOGY, INC.

Health Technology

Private companies3

Electronic Technology

Technology Services

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Richard Williams